MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 193 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2018. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,229,000 | +291.1% | 70,694 | +84.9% | 0.07% | +231.8% |
| Q3 2018 | $570,000 | +31.3% | 38,229 | +40.0% | 0.02% | +29.4% |
| Q2 2018 | $434,000 | +36.5% | 27,300 | +26.3% | 0.02% | +30.8% |
| Q1 2018 | $318,000 | +46.5% | 21,620 | +39.2% | 0.01% | +30.0% |
| Q4 2017 | $217,000 | +27.6% | 15,528 | +44.2% | 0.01% | -28.6% |
| Q2 2017 | $170,000 | -73.5% | 10,771 | -71.3% | 0.01% | -84.3% |
| Q3 2015 | $642,000 | -2.1% | 37,525 | +6.6% | 0.09% | +2.3% |
| Q2 2015 | $656,000 | +2.8% | 35,214 | +5.4% | 0.09% | -32.0% |
| Q1 2015 | $638,000 | +71.0% | 33,425 | +47.6% | 0.13% | +1.6% |
| Q4 2014 | $373,000 | – | 22,639 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |